Development and initial validation of the MS score for diagnosis of macrophage activation syndrome in systemic juvenile idiopathic arthritis
Francesca Minoia(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Angelo Ravelli(Istituto Giannina Gaslini), Clóvis A. Silva(Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo), Marija Jelušić(University Hospital Centre Zagreb), Alberto Martini(Istituto Giannina Gaslini), Randy Q. Cron(University of Alabama at Birmingham), AnnaCarin Horne(Karolinska University Hospital), Michael Frosch(University Hospital Münster), Donato Rigante(Istituti di Ricovero e Cura a Carattere Scientifico), Michel Fischbach(Hôpital d'Hautepierre), Sergio Davì(Istituto Giannina Gaslini), Erbil Ünsal(Dokuz Eylül University), Sujata Sawhney(Sir Ganga Ram Hospital), Nicolino Ruperto(Istituto Giannina Gaslini), Francesca Bovis(Istituto Giannina Gaslini), Deborah McCurdy(University of California, Los Angeles), Adam M. Huber(Izaak Walton Killam Health Centre)
Cited by 109
Related Papers
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k
Drug Retention Rate and Predictive Factors of Drug Survival for Interleukin-1 Inhibitors in Systemic Juvenile Idiopathic Arthritis
|Frontiers in Pharmacology|2019|616
Clinical Features, Treatment, and Outcome of Macrophage Activation Syndrome Complicating Systemic Juvenile Idiopathic Arthritis: A Multinational, Multicenter Study of 362 Patients
|Arthritis & Rheumatology|2014|430
Identification of <i>IRAK1</i> as a risk gene with critical role in the pathogenesis of systemic lupus erythematosus
|Proceedings of the National Academy of Sciences|2009|240
Phenotypic variability and disparities in treatment and outcomes of childhood arthritis throughout the world: an observational cohort study
|The Lancet Child & Adolescent Health|2019|214